Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002712483 | SCV003552608 | uncertain significance | Inborn genetic diseases | 2021-02-05 | criteria provided, single submitter | clinical testing | The c.3766G>A (p.V1256I) alteration is located in exon 6 (coding exon 6) of the NHS gene. This alteration results from a G to A substitution at nucleotide position 3766, causing the valine (V) at amino acid position 1256 to be replaced by an isoleucine (I). Based on data from the Genome Aggregation Database (gnomAD), the NHS c.3766G>A alteration was not observed, with coverage at this position. The p.V1256 amino acid is not conserved in available vertebrate species. The p.V1256I alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |